Men diagnosed at this hospital trust can access the following services:

• Diagnostic Facilities:
• Multiparametric MRI
• Choline PET
• PSMA (prostate-specific membrane antigen) PET scan
• Isotope bone scan

For Wales, this data completeness relates to patients diagnosed between April 2022 and March 2023.
For England, this data completeness relates to patients diagnosed in 2021. This is the data completeness of the National Cancer Registration Dataset (NCRD). For data completeness of the Rapid Cancer Registration Dataset (RCRD), please refer to the NPCA quarterly reports.

	Diagnosing Trust	Specialist MDT
No. of Cancer Registry records	531	980
Performance Status recorded	100%	100%
PSA completed	91%	87%
Gleason Score completed	91%	87%
TNM completed	81%	73%
Risk group assigned	97%	97%

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

	Specialist MDT	National
No. of men with disease status determined	963	39897
Percentage of men diagnosed with metastatic disease	17%	17%

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

	Specialist MDT	National
No. of men diagnosed with low-risk localised disease	176	4684
Percentage of men with low-risk localised disease receiving radical treatment	16%	8%
No. of men diagnosed with locally advanced disease	296	15410
Percentage of men diagnosed with locally advanced disease receiving radical treatment	71%	68%

	Treatment Centre
No. of men who received radical prostatectomy (April 2022- March 2023)	38
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%)	20%
No. of men who received radical prostatectomy (September 2020 - August 2021)	20
Adjusted percentage of men experiencing at least one GU complication (%)	11%
No. of men who received radical radiotherapy (September 2020 - August 2021)	137
Adjusted percentage of men experiencing at least one GI complication (%)	10%